RecruitingPhase 3NCT07654374A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsMoore, OK · Tulsa, OK · Yukon, OK · +71 more sites
RecruitingPhase 3NCT07351045A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesSponsor: Hoffmann-La RocheTulsa, OK · +43 more sites
RecruitingPhase 3NCT07667803A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMSponsor: AstraZenecaOklahoma City, OK · Tulsa, OK · +54 more sites
RecruitingPhase 3NCT07784725A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusSponsor: AstraZenecaTulsa, OK · +32 more sites
Not yet recruitingPhase 3NCT07668336A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesSponsor: Eli Lilly and CompanyTulsa, OK · +16 more sites